IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,592,912 | -49.2% | 167,588 | -68.6% | 0.08% | -54.4% |
| Q1 2023 | $12,987,792 | -22.5% | 533,818 | -31.8% | 0.18% | -27.2% |
| Q4 2022 | $16,758,078 | +24.3% | 782,722 | +4.2% | 0.25% | +22.5% |
| Q3 2022 | $13,482,000 | +25.5% | 751,490 | -32.7% | 0.20% | +17.2% |
| Q2 2022 | $10,740,000 | -24.5% | 1,116,401 | +32.1% | 0.17% | -0.6% |
| Q1 2022 | $14,218,000 | -1.2% | 844,814 | -1.9% | 0.18% | +19.0% |
| Q4 2021 | $14,397,000 | -4.9% | 861,041 | -7.7% | 0.15% | -18.3% |
| Q3 2021 | $15,143,000 | – | 932,432 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |